Quarterly report pursuant to Section 13 or 15(d)

Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs

v3.23.1
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs - $ / shares
 2 Months Ended 3 Months Ended
Mar. 03, 2023
Mar. 31, 2023
Tranche A Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Fair value of underlying stock (in Dollars per share) $ 0.49 $ 2.1
Dividend yield 0.00% 0.00%
Discount for lack of marketability 20.00% 25.00%
Probability for shareholder approval 45.00% 45.00%
Tranche B Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Fair value of underlying stock (in Dollars per share) $ 0.49 $ 2.1
Dividend yield 0.00% 0.00%
Discount for lack of marketability 20.00% 25.00%
Probability for shareholder approval 45.00% 45.00%
Tranche C Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Fair value of underlying stock (in Dollars per share) $ 0.49 $ 2.1
Dividend yield 0.00% 0.00%
Discount for lack of marketability 20.00% 25.00%
Probability for shareholder approval 45.00% 45.00%
Minimum [Member] | Tranche A Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Volatility 90.20% 109.50%
Risk free rate 4.70% 4.10%
Term (in years) 1 year 3 months 18 days 1 year 3 months 18 days
Probability for FDA approval 16.00% 16.00%
Minimum [Member] | Tranche B Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Volatility 93.70% 108.50%
Risk free rate 4.60% 3.90%
Term (in years) 1 year 9 months 18 days 1 year 9 months 18 days
Probability for TDAPA approval 0.00% 0.00%
Minimum [Member] | Tranche C Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Volatility 97.10% 103.60%
Risk free rate 4.50% 3.70%
Term (in years) 2 years 9 months 18 days 2 years 9 months 18 days
Probability for commercialization 2.70% 2.70%
Maximum [Member] | Tranche A Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Volatility 94.60% 128.20%
Risk free rate 5.00% 4.50%
Term (in years) 2 years 3 months 18 days 2 years 3 months 18 days
Probability for FDA approval 31.90% 31.90%
Maximum [Member] | Tranche B Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Volatility 95.80% 110.00%
Risk free rate 4.90% 4.30%
Term (in years) 2 years 9 months 18 days 2 years 9 months 18 days
Probability for TDAPA approval 20.00% 20.00%
Maximum [Member] | Tranche C Warrant [Member]    
Warrant Liability (Details) - Schedule of valuation of the warrants contained unobservable inputs [Line Items]    
Volatility 103.90% 109.80%
Risk free rate 4.60% 3.90%
Term (in years) 3 years 9 months 18 days 3 years 9 months 18 days
Probability for commercialization 9.10% 9.10%